SEC 13F Intelligence

Rheos Capital Works Inc. / AKRO

Rheos Capital Works Inc.’s Akero Therapeutics Inc Com Position

Does Rheos Capital Works Inc. own Akero Therapeutics Inc Com (AKRO)? Not currently — the last reported position was 276.0K shares worth $11M in Q1 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$11M
Q1 2025
Shares
276.0K
% of Portfolio
+0.91%
Quarters Held
4
position exited

Position History AKRO

Reported value by quarter
Q2 ’24: $5MQ2 ’24Q3 ’24: $8MQ3 ’24Q4 ’24: $8MQ4 ’24Q1 ’25: $11MQ1 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2025276.0K$11M+0.91%
Q4 2024276.0K$8M+0.43%
Q3 2024276.0K$8M+0.41%
Q2 2024216.0K$5M+0.27%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Rheos Capital Works Inc.’s full portfolio or all institutional holders of AKRO.